These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33624446)

  • 1. Tumour angiogenesis normalized by myo-inositol trispyrophosphate alleviates hypoxia in the microenvironment and promotes antitumor immune response.
    El Hafny-Rahbi B; Brodaczewska K; Collet G; Majewska A; Klimkiewicz K; Delalande A; Grillon C; Kieda C
    J Cell Mol Med; 2021 Apr; 25(7):3284-3299. PubMed ID: 33624446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable tumor vessel normalization with pO₂ increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment.
    Kieda C; El Hafny-Rahbi B; Collet G; Lamerant-Fayel N; Grillon C; Guichard A; Dulak J; Jozkowicz A; Kotlinowski J; Fylaktakidou KC; Vidal A; Auzeloux P; Miot-Noirault E; Beloeil JC; Lehn JM; Nicolau C
    J Mol Med (Berl); 2013 Jul; 91(7):883-99. PubMed ID: 23471434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour suppressor PTEN activity is differentially inducible by myo-inositol phosphates.
    Grzymajlo K; El Hafny-Rahbi B; Kieda C
    J Cell Mol Med; 2023 Mar; 27(6):879-890. PubMed ID: 36852461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy.
    Raykov Z; Grekova SP; Bour G; Lehn JM; Giese NA; Nicolau C; Aprahamian M
    Int J Cancer; 2014 Jun; 134(11):2572-82. PubMed ID: 24214898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of myo-inositol trispyrophosphate (ITPP) on tumour oxygenation and response to irradiation in rodent tumour models.
    Tran LB; Cao-Pham TT; Jordan BF; Deschoemaeker S; Heyerick A; Gallez B
    J Cell Mol Med; 2019 Mar; 23(3):1908-1916. PubMed ID: 30575283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypoxic Potentiation of Standard Therapy for Experimental Colorectal Liver Metastasis through Myo-Inositol Trispyrophosphate.
    Limani P; Linecker M; Kachaylo E; Tschuor C; Kron P; Schlegel A; Ungethuem U; Jang JH; Georgiopoulou S; Nicolau C; Lehn JM; Graf R; Humar B; Clavien PA
    Clin Cancer Res; 2016 Dec; 22(23):5887-5897. PubMed ID: 27489288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes.
    Kieda C; Greferath R; Crola da Silva C; Fylaktakidou KC; Lehn JM; Nicolau C
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15576-81. PubMed ID: 17028170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma.
    Sihn G; Walter T; Klein JC; Queguiner I; Iwao H; Nicolau C; Lehn JM; Corvol P; Gasc JM
    FEBS Lett; 2007 Mar; 581(5):962-6. PubMed ID: 17316624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Oxygenation by Myo-Inositol Trispyrophosphate Enhances Radiation Response.
    Grgic I; Tschanz F; Borgeaud N; Gupta A; Clavien PA; Guckenberger M; Graf R; Pruschy M
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1222-1233. PubMed ID: 33587991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen therapeutic window induced by myo-inositol trispyrophosphate (ITPP)-Local pO2 study in murine tumors.
    Krzykawska-Serda M; Szczygieł D; Gaweł S; Drzał A; Szczygieł M; Kmieć MM; Mackiewicz A; Kieda C; Elas M
    PLoS One; 2023; 18(5):e0285318. PubMed ID: 37167239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing the oxygen load by treatment with myo-inositol trispyrophosphate reduces growth of colon cancer and modulates the intestine homeobox gene Cdx2.
    Derbal-Wolfrom L; Pencreach E; Saandi T; Aprahamian M; Martin E; Greferath R; Tufa E; Choquet P; Lehn JM; Nicolau C; Duluc I; Freund JN
    Oncogene; 2013 Sep; 32(36):4313-8. PubMed ID: 23045284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate.
    Biolo A; Greferath R; Siwik DA; Qin F; Valsky E; Fylaktakidou KC; Pothukanuri S; Duarte CD; Schwarz RP; Lehn JM; Nicolau C; Colucci WS
    Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1926-9. PubMed ID: 19204295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypoxia-dependent cardiovascular diseases by myo-inositol trispyrophosphate (ITPP)-enhancement of oxygen delivery by red blood cells.
    Oknińska M; El-Hafny-Rahbi B; Paterek A; Mackiewicz U; Crola-Da Silva C; Brodaczewska K; Mączewski M; Kieda C
    J Cell Mol Med; 2020 Feb; 24(3):2272-2283. PubMed ID: 31957267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity.
    Tanegashima T; Togashi Y; Azuma K; Kawahara A; Ideguchi K; Sugiyama D; Kinoshita F; Akiba J; Kashiwagi E; Takeuchi A; Irie T; Tatsugami K; Hoshino T; Eto M; Nishikawa H
    Clin Cancer Res; 2019 Aug; 25(15):4808-4819. PubMed ID: 31076547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
    Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
    Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of Inositol Trispyrophosphate to Enhance Highly Effective Radiotherapy of GL261 Glioblastoma in Mice.
    Iyengar S; Schwartz D
    Anticancer Res; 2017 Mar; 37(3):1121-1125. PubMed ID: 28314273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myo-InositolTrisPyroPhosphate treatment leads to HIF-1α suppression and eradication of early hepatoma tumors in rats.
    Aprahamian M; Bour G; Akladios CY; Fylaktakidou K; Greferath R; Soler L; Marescaux J; Egly JM; Lehn JM; Nicolau C
    Chembiochem; 2011 Mar; 12(5):777-83. PubMed ID: 21370375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
    Jarosz-Biej M; Kamińska N; Matuszczak S; Cichoń T; Pamuła-Piłat J; Czapla J; Smolarczyk R; Skwarzyńska D; Kulik K; Szala S
    PLoS One; 2018; 13(1):e0191012. PubMed ID: 29320562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.